Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Achieve Life Sciences, Inc. before investing.

In this article, we go over a few key elements for understanding Achieve Life Sciences, Inc.’s stock price such as:

• Achieve Life Sciences, Inc.’s current stock price and volume
• Why Achieve Life Sciences, Inc.’s stock price changed recently
• Upgrades and downgrades for ACHV from analysts
• ACHV’s stock price momentum as measured by its relative strength

About Achieve Life Sciences, Inc. (ACHV)

Before we jump into Achieve Life Sciences, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Want to learn more about Achieve Life Sciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Achieve Life Sciences, Inc..

Achieve Life Sciences, Inc.’s Stock Price as of Market Close

As of December 05, 2025, 4:00 PM, CST, Achieve Life Sciences, Inc.’s stock price was $4.620.

Achieve Life Sciences, Inc. is down 3.35% from its previous closing price of $4.780.

During the last market session, Achieve Life Sciences, Inc.’s stock traded between $4.590 and $4.850. Currently, there are approximately 51.02 million shares outstanding for Achieve Life Sciences, Inc..

Achieve Life Sciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Achieve Life Sciences, Inc. Stock Price History

Achieve Life Sciences, Inc.’s (ACHV) price is currently down 5.13% so far this month.

During the month of December, Achieve Life Sciences, Inc.’s stock price has reached a high of $5.190 and a low of $4.450.

Over the last year, Achieve Life Sciences, Inc. has hit prices as high as $5.780 and as low as $1.840. Year to date, Achieve Life Sciences, Inc.’s stock is up 31.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Achieve Life Sciences, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 05, 2025, there were 0 analysts who downgraded Achieve Life Sciences, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Achieve Life Sciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Achieve Life Sciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Achieve Life Sciences, Inc. (ACHV) by visiting AAII Stock Evaluator.

Relative Price Strength of Achieve Life Sciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 05, 2025, Achieve Life Sciences, Inc. has a weighted four-quarter relative price strength of 9.10%, which translates to a Momentum Score of 81 and is considered to be Very Strong.

Want to learn more about how Achieve Life Sciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Achieve Life Sciences, Inc. Stock Price: Bottom Line

As of December 5, 2025, Achieve Life Sciences, Inc.’s stock price is $4.620, which is down 3.35% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Achieve Life Sciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.